Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2023 Jun 16:25:e38275.
doi: 10.2196/38275.

Effect of Mobile Phone Text Messaging Self-Management Support for Patients With Diabetes or Coronary Heart Disease in a Chronic Disease Management Program (SupportMe) on Blood Pressure: Pragmatic Randomized Controlled Trial

Ngai Wah Cheung  1   2 , Julie Redfern  3 , Aravinda Thiagalingam  4 , Tien-Ming Hng  5 , Simone Marschner  2 , Rabbia Haider  1 , Sonia Faruquie  1 , Amy Von Huben  2 , Shelley She  2 , Daniel McIntyre  2 , Jin-Gun Cho  6 , Clara K Chow  2   4 ; SupportMe Investigators  7
Collaborators, Affiliations
Randomized Controlled Trial

Effect of Mobile Phone Text Messaging Self-Management Support for Patients With Diabetes or Coronary Heart Disease in a Chronic Disease Management Program (SupportMe) on Blood Pressure: Pragmatic Randomized Controlled Trial

Ngai Wah Cheung et al. J Med Internet Res. .

Abstract

Background: Maintaining engagement and support for patients with chronic diseases is challenging. SMS text messaging programs have complemented patient care in a variety of situations. However, such programs have not been widely translated into routine care.

Objective: We aimed to examine the implementation and utility of a customized SMS text message-based support program for patients with type 2 diabetes (T2D), coronary heart disease, or both within a chronic disease integrated care program.

Methods: We conducted a 6-month pragmatic parallel-group, single-blind randomized controlled trial that recruited people with T2D or coronary heart disease. Intervention participants received 4 semipersonalized SMS text messages per week providing self-management support to supplement standard care. Preprogrammed algorithms customized content based on participant characteristics, and the messages were sent at random times of the day and in random order by a fully automated SMS text messaging engine. Control participants received standard care and only administrative SMS text messages. The primary outcome was systolic blood pressure. Evaluations were conducted face to face whenever possible by researchers blinded to randomization. Participants with T2D were evaluated for glycated hemoglobin level. Participant-reported experience measures were evaluated using questionnaires and focus groups and summarized using proportions and thematic analysis.

Results: A total of 902 participants were randomized (n=448, 49.7% to the intervention group and n=454, 50.3% to the control group). Primary outcome data were available for 89.5% (807/902) of the participants. At 6 months, there was no difference in systolic blood pressure between the intervention and control arms (adjusted mean difference=0.9 mm Hg, 95% CI -1.1 to 2.1; P=.38). Of 642 participants with T2D, there was no difference in glycated hemoglobin (adjusted mean difference=0.1%, 95% CI -0.1% to 0.3%; P=.35). Self-reported medication adherence was better in the intervention group (relative risk=0.82, 95% CI 0.68-1.00; P=.045). Participants reported that the SMS text messages were useful (298/344, 86.6%) and easily understood (336/344, 97.7%) and motivated change (217/344, 63.1%). The lack of bidirectional messaging was identified as a barrier.

Conclusions: The intervention did not improve blood pressure in this cohort, possibly because of high clinician commitment to improved routine patient care as part of the chronic disease management program as well as favorable baseline metrics. There was high program engagement, acceptability, and perceived value. Feasibility as part of an integrated care program was demonstrated. SMS text messaging programs may supplement chronic disease management and support self-care.

Trial registration: Australian New Zealand Clinical Trials Registry ACTRN12616001689460; https://anzctr.org.au/Trial/Registration/TrialReview.aspx?id=371769&isReview=true.

International registered report identifier (irrid): RR2-10.1136/bmjopen-2018-025923.

Keywords: SMS text messaging; chronic disease; coronary disease; delivery of health care; diabetes mellitus; integrated; self-management; type 2.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: JR is part owner of Textcare IP and holds a National Health and Medical Research Council (NHMRC) Investigator Grant Leadership Level 2.

Figures

Figure 1
Figure 1
CONSORT (Consolidated Standards of Reporting Trials) diagram for the SupportMe randomized controlled trial. *Excluding 1 participant who was inadvertently randomized twice. CHD: coronary heart disease; HbA1c: glycated hemoglobin; T2D: type 2 diabetes.
Figure 2
Figure 2
Interaction between subgroups by treatment group for the primary outcome (systolic blood pressure [SBP]). GP: general practitioner; LDL: low-density lipoprotein; NZ: New Zealander.
Figure 3
Figure 3
Interaction between subgroups by treatment group for the glycated hemoglobin (HbA1c) results at the 6-month assessment among participants with suboptimally controlled type 2 diabetes. GP: general practitioner; LDL: low-density lipoprotein; NZ: New Zealander; SBP: systolic blood pressure.
See this image and copyright information in PMC

References

    1. GBD 2015 Mortality and Causes of Death Collaborators Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016 Oct 08;388(10053):1459–1544. doi: 10.1016/S0140-6736(16)31012-1. https://linkinghub.elsevier.com/retrieve/pii/S0140-6736(16)31012-1 S0140-6736(16)31012-1 - DOI - PMC - PubMed
    1. Golics CJ, Basra MK, Finlay AY, Salek S. The impact of disease on family members: a critical aspect of medical care. J R Soc Med. 2013 Oct;106(10):399–407. doi: 10.1177/0141076812472616. https://europepmc.org/abstract/MED/23759884 0141076812472616 - DOI - PMC - PubMed
    1. Schofield D, Shrestha RN, Cunich MM, Tanton R, Veerman L, Kelly SJ, Passey ME. Economic costs of chronic disease through lost productive life years (PLYs) among Australians aged 45-64 years from 2015 to 2030: results from a microsimulation model. BMJ Open. 2016 Sep 22;6(9):e011151. doi: 10.1136/bmjopen-2016-011151. https://bmjopen.bmj.com/lookup/pmidlookup?view=long&pmid=27660315 bmjopen-2016-011151 - DOI - PMC - PubMed
    1. Scott-Sheldon LA, Lantini R, Jennings EG, Thind H, Rosen RK, Salmoirago-Blotcher E, Bock BC. Text messaging-based interventions for smoking cessation: a systematic review and meta-analysis. JMIR Mhealth Uhealth. 2016;4(2):e49. doi: 10.2196/mhealth.5436. http://mhealth.jmir.org/2016/2/e49/ v4i2e49 - DOI - PMC - PubMed
    1. Whittaker R, McRobbie H, Bullen C, Rodgers A, Gu Y. Mobile phone-based interventions for smoking cessation. Cochrane Database Syst Rev. 2016 Apr 10;4(4):CD006611. doi: 10.1002/14651858.CD006611.pub4. https://europepmc.org/abstract/MED/27060875 - DOI - PMC - PubMed

Publication types

Substances